Skip to main content
Top
Published in: Annals of Hematology 6/2004

01-06-2004 | Case Report

Acute megakaryoblastic leukaemia with extreme thrombocytosis and p190 bcr/abl rearrangement

Authors: G. Balatzenko, M. Guenova, J. Zechev, S. Toshkov

Published in: Annals of Hematology | Issue 6/2004

Login to get access

Abstract

Acute megakaryoblastic leukaemia (AML-M7) is an uncommon disease, composing 0.5–1.2% of newly diagnosed adult acute myeloid leukaemias (AML). It is characterised by higher incidence and complexity of cytogenetic abnormalities. We report a rare case of Philadelphia (Ph) chromosome-positive AML-M7, presenting with extreme thrombocytosis and having a poor outcome. The diagnosis was established on the basis of morphological and flow cytometry data for megakaryoblastic proliferation in the bone marrow. Cytogenetics revealed 47,XX,+8,t(9;22)(q34;q11), and p190BCR-ABL-rearrangement was detected. MDR1-gene overexpression was not demonstrated; however, the patient was resistant to therapy and died in 6 months. The reported case contributes to the overt heterogeneity of Ph-positive AMLs, which warrants further investigation and understanding.
Literature
1.
go back to reference Borek C, Guernsey DL, Ong A, Edelman IS (1983) Critical role played by thyroid hormone in induction of neoplastic transformation by chemical carcinogens in tissue culture. Proc Natl Acad Sci USA 80:5749–5752PubMed Borek C, Guernsey DL, Ong A, Edelman IS (1983) Critical role played by thyroid hormone in induction of neoplastic transformation by chemical carcinogens in tissue culture. Proc Natl Acad Sci USA 80:5749–5752PubMed
2.
go back to reference Cuneo A, Ferrant A, Michaux JL, Demuynck H, Boogaerts M, Louwagie A, Doyen C, Stul M, Cassiman JJ, Dal Cin P, Castoldi G, Van den Berghe H (1996) Philadelphia chromosome-positive acute myeloid leukemia: cytoimmunologic and cytogenetic features. Haematologica 81:423–427PubMed Cuneo A, Ferrant A, Michaux JL, Demuynck H, Boogaerts M, Louwagie A, Doyen C, Stul M, Cassiman JJ, Dal Cin P, Castoldi G, Van den Berghe H (1996) Philadelphia chromosome-positive acute myeloid leukemia: cytoimmunologic and cytogenetic features. Haematologica 81:423–427PubMed
3.
go back to reference Dastugue N, Lafage-Pochitaloff M, Pagès M-P, Radford I, Bastard C, Talmant P, Mozziconacci MJ, LéonardC, Bilhou-Nabéra C, Cabrol C, Capodano A-M, Cornillet-Lefebvre P, Lessard M, Mugneret F, Pérot C, Taviaux S, Fenneteaux O, Duchayne E, Berger R, on behalf of the Groupe Français de Cytogénétique Hématologique (GFCH) and with the contribution of the Groupe Français d’Hématologie Cellulaire (GFHC) (2002) Cytogenetic profile of childhood and adult megakaryoblastic leukemia (M7): a study of the Groupe Français de Cytogénétique Hématologique (GFCH). Blood 100:618–626CrossRefPubMed Dastugue N, Lafage-Pochitaloff M, Pagès M-P, Radford I, Bastard C, Talmant P, Mozziconacci MJ, LéonardC, Bilhou-Nabéra C, Cabrol C, Capodano A-M, Cornillet-Lefebvre P, Lessard M, Mugneret F, Pérot C, Taviaux S, Fenneteaux O, Duchayne E, Berger R, on behalf of the Groupe Français de Cytogénétique Hématologique (GFCH) and with the contribution of the Groupe Français d’Hématologie Cellulaire (GFHC) (2002) Cytogenetic profile of childhood and adult megakaryoblastic leukemia (M7): a study of the Groupe Français de Cytogénétique Hématologique (GFCH). Blood 100:618–626CrossRefPubMed
4.
go back to reference Gassmann W, Loffler H (1995) Acute megakaryoblastic leukemia. Leuk Lymphoma 18:69–73 Gassmann W, Loffler H (1995) Acute megakaryoblastic leukemia. Leuk Lymphoma 18:69–73
5.
go back to reference Jaffe ES, Harris NL, Stein H, Vardiman JW (2001) World Health Organization Classification of Tumours. Pathology and genetics of tumours of the haemopoietic and lymphoid tissues. IARC Press, Lyon, France Jaffe ES, Harris NL, Stein H, Vardiman JW (2001) World Health Organization Classification of Tumours. Pathology and genetics of tumours of the haemopoietic and lymphoid tissues. IARC Press, Lyon, France
6.
go back to reference Katsuno M, Yamashita S, Sadamura S, Umemura T, Hirata J, Nishimura J, Nawata H (1994) Late-appearing Philadelphia chromosome in a patient with acute nonlymphocytic leukaemia derived from myelodysplastic syndrome: detection of P210- and P190-type bcr/abl fusion gene transcripts at the leukaemic stage. Br J Haematol 87:51–56 Katsuno M, Yamashita S, Sadamura S, Umemura T, Hirata J, Nishimura J, Nawata H (1994) Late-appearing Philadelphia chromosome in a patient with acute nonlymphocytic leukaemia derived from myelodysplastic syndrome: detection of P210- and P190-type bcr/abl fusion gene transcripts at the leukaemic stage. Br J Haematol 87:51–56
7.
go back to reference Kunieda Y, Okabe M, Kurosawa M, Itaya T, Kakinuma M, Miyazaki T (1994) Chronic myeloid leukemia presenting ALL-type BCR/ABL transcript. Ann Hematol 69:189–193PubMed Kunieda Y, Okabe M, Kurosawa M, Itaya T, Kakinuma M, Miyazaki T (1994) Chronic myeloid leukemia presenting ALL-type BCR/ABL transcript. Ann Hematol 69:189–193PubMed
8.
go back to reference Lesesve JF, Troussard X, Bastard C, Hurst JP, Nouet D, Callat MP, Lenormand B, Piguet H, Flandrin G, Macintyre E (1996) p190bcr/abl rearrangement in myelodysplastic syndromes: two reports and review of the literature. Br J Haematol 95:372–375PubMed Lesesve JF, Troussard X, Bastard C, Hurst JP, Nouet D, Callat MP, Lenormand B, Piguet H, Flandrin G, Macintyre E (1996) p190bcr/abl rearrangement in myelodysplastic syndromes: two reports and review of the literature. Br J Haematol 95:372–375PubMed
9.
go back to reference Marie JP, Huet S, Faussat AM, Perrot JY, Chevillard S, Barbu V, Bayle C, Boutonnat J, Calvo F, Campos-Guyotat L, Colosetti P, Cazin JL, de Cremoux P, Delvincourt C, Demur C, Drenou B, Fenneteau O, Feuillard J, Garnier-Suillerot A, Genne P, Gorisse MC, Gosselin P, Jouault H, Lacave R, Robert J, et al (1997) Multicentric evaluation of the MDR phenotype in leukemia. French Network of the Drug Resistance Intergroup, and Drug Resistance Network of Assistance Publique-Hopitaux de Paris. Leukemia 11:1086–1094CrossRefPubMed Marie JP, Huet S, Faussat AM, Perrot JY, Chevillard S, Barbu V, Bayle C, Boutonnat J, Calvo F, Campos-Guyotat L, Colosetti P, Cazin JL, de Cremoux P, Delvincourt C, Demur C, Drenou B, Fenneteau O, Feuillard J, Garnier-Suillerot A, Genne P, Gorisse MC, Gosselin P, Jouault H, Lacave R, Robert J, et al (1997) Multicentric evaluation of the MDR phenotype in leukemia. French Network of the Drug Resistance Intergroup, and Drug Resistance Network of Assistance Publique-Hopitaux de Paris. Leukemia 11:1086–1094CrossRefPubMed
10.
go back to reference Melo J (1996) The diversity of bcr-abl fusion proteins and their relationships to leukemia phenotype. Blood 88:2375–2384PubMed Melo J (1996) The diversity of bcr-abl fusion proteins and their relationships to leukemia phenotype. Blood 88:2375–2384PubMed
11.
go back to reference Mrozek K, Heinonen K, Bloomfeld CD (2001) Clinical importance of cytogenetics in acute myeloid leukaemia. Best Pract Res Clin Haematol 14:19–47CrossRefPubMed Mrozek K, Heinonen K, Bloomfeld CD (2001) Clinical importance of cytogenetics in acute myeloid leukaemia. Best Pract Res Clin Haematol 14:19–47CrossRefPubMed
12.
go back to reference Pagano L, Pulsoni A, Vignetti M, Mele L, Fianchi L, Petti MC, Mirto S, Falcucci P, Fazi P, Broccia G, Specchia G, Di Raimondo F, Pacilli L, Leoni P, Ladogana S, Gallo E, Venditti A, Avanzi G, Camera A, Liso V, Leone G, Mandelli F; GIMEMA (2002) Acute megakaryoblastic leukemia: experience of GIMEMA trials. Leukemia 16:1622–1626CrossRefPubMed Pagano L, Pulsoni A, Vignetti M, Mele L, Fianchi L, Petti MC, Mirto S, Falcucci P, Fazi P, Broccia G, Specchia G, Di Raimondo F, Pacilli L, Leoni P, Ladogana S, Gallo E, Venditti A, Avanzi G, Camera A, Liso V, Leone G, Mandelli F; GIMEMA (2002) Acute megakaryoblastic leukemia: experience of GIMEMA trials. Leukemia 16:1622–1626CrossRefPubMed
13.
go back to reference Paietta E, Racevskis J, Bennett JM, Neuberg D, Cassileth PA, Rowe JM, Wiernik PH (1998) Biologic heterogeneity in Philadelphia chromosome-positive acute leukemia with myeloid morphology: the Eastern Cooperative Oncology Group experience. Leukemia 12:1881–1885CrossRefPubMed Paietta E, Racevskis J, Bennett JM, Neuberg D, Cassileth PA, Rowe JM, Wiernik PH (1998) Biologic heterogeneity in Philadelphia chromosome-positive acute leukemia with myeloid morphology: the Eastern Cooperative Oncology Group experience. Leukemia 12:1881–1885CrossRefPubMed
14.
go back to reference Peterson BA, Levine EG (1987) Uncommon subtypes of acute non-lymphocytic leukemia. Clinical features and management of FAB M5, M6 and M7. Semin Oncol 14:425–435PubMed Peterson BA, Levine EG (1987) Uncommon subtypes of acute non-lymphocytic leukemia. Clinical features and management of FAB M5, M6 and M7. Semin Oncol 14:425–435PubMed
15.
go back to reference Ribeiro RC, Oliveira MS, Fairclough D, Hurwitz C, Mirro J, Behm FG, Head D, Silva ML, Raimondi SC, Crist WM, et al (1993) Acute megakaryoblastic leukemia in children and adolescents: a retrospective analysis of 24 cases. Leuk Lymphoma 10:299–306PubMed Ribeiro RC, Oliveira MS, Fairclough D, Hurwitz C, Mirro J, Behm FG, Head D, Silva ML, Raimondi SC, Crist WM, et al (1993) Acute megakaryoblastic leukemia in children and adolescents: a retrospective analysis of 24 cases. Leuk Lymphoma 10:299–306PubMed
16.
go back to reference Roumier C, Daudignon A, Soenen V, Dupriez B, Wetterwald M, Lai JL, Cosson A, Fenaux P, Preudhomme C (1999) P190 bcr-abl rearrangement: a secondary cytogenetic event in some chronic myeloid disorders? Haematologica 84:1075–1080PubMed Roumier C, Daudignon A, Soenen V, Dupriez B, Wetterwald M, Lai JL, Cosson A, Fenaux P, Preudhomme C (1999) P190 bcr-abl rearrangement: a secondary cytogenetic event in some chronic myeloid disorders? Haematologica 84:1075–1080PubMed
17.
go back to reference Tallman MS, Neuberg D, Bennett JM, Francois CJ, Paietta E, Wiernik PH, Dewald G, Cassileth PA, Oken MM, Rowe JM (2000) Acute megakaryocytic leukemia: the Eastern Cooperative Oncology Group experience. Blood 96:2405–2411PubMed Tallman MS, Neuberg D, Bennett JM, Francois CJ, Paietta E, Wiernik PH, Dewald G, Cassileth PA, Oken MM, Rowe JM (2000) Acute megakaryocytic leukemia: the Eastern Cooperative Oncology Group experience. Blood 96:2405–2411PubMed
18.
go back to reference van Dongen JJ, Macintyre EA, Gabert JA, Delabesse E, Rossi V, Saglio G, Gottardi E, Rambaldi A, Dotti G, Griesinger F, Parreira A, Gameiro P, Diaz MG, Malec M, Langerak AW, San Miguel JF, Biondi A (1999) Standardised RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 concerted action: investigation of minimal residual disease in acute leukemia. Leukemia 13:1901–1928CrossRefPubMed van Dongen JJ, Macintyre EA, Gabert JA, Delabesse E, Rossi V, Saglio G, Gottardi E, Rambaldi A, Dotti G, Griesinger F, Parreira A, Gameiro P, Diaz MG, Malec M, Langerak AW, San Miguel JF, Biondi A (1999) Standardised RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 concerted action: investigation of minimal residual disease in acute leukemia. Leukemia 13:1901–1928CrossRefPubMed
19.
go back to reference Vandenberghe E, Martiat P, Baens M, Stul M, Ferrant A, Cuneo A, Cassiman JJ, Mecucci C, Van den Berghe H (1991) Megakaryoblastic leukemia with an N-ras mutation and late acquisition of a Philadelphia chromosome. Leukemia 5:683–686PubMed Vandenberghe E, Martiat P, Baens M, Stul M, Ferrant A, Cuneo A, Cassiman JJ, Mecucci C, Van den Berghe H (1991) Megakaryoblastic leukemia with an N-ras mutation and late acquisition of a Philadelphia chromosome. Leukemia 5:683–686PubMed
20.
go back to reference Veelken H, Licht T, Lais A, Kohler G, Mertelsmann R, Schaefer HE, Lubbert M (1998) Drug resistance of secondary acute myeloid leukemia with megakaryoblastic features and p190 BCR-ABL rearrangement. Leuk Res 22:1021–1027CrossRefPubMed Veelken H, Licht T, Lais A, Kohler G, Mertelsmann R, Schaefer HE, Lubbert M (1998) Drug resistance of secondary acute myeloid leukemia with megakaryoblastic features and p190 BCR-ABL rearrangement. Leuk Res 22:1021–1027CrossRefPubMed
Metadata
Title
Acute megakaryoblastic leukaemia with extreme thrombocytosis and p190 bcr/abl rearrangement
Authors
G. Balatzenko
M. Guenova
J. Zechev
S. Toshkov
Publication date
01-06-2004
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 6/2004
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-003-0783-1

Other articles of this Issue 6/2004

Annals of Hematology 6/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine